サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Organ Function Assays - Medical Devices Pipeline Assessment, 2019

内臓機能アッセイ−医療機器パイプライン評価2019年

レポート概要

本レポートは、開発段階にある内臓機能アッセイの概要を明らかにします。

本レポートは、パイプライン製品に関する包括的な情報を提供し、さまざまな開発段階での製品の比較分析を行います。また、パイプライン製品開発に携わる主要企業をレビューし、進行中の臨床試験についての情報も提供します。臨床試験には、主要な内臓機能アッセイパイプライン製品の治験段階、治験状況、治験開始日と終了日、治験数が含まれます。

本レポートは、GlobalData社の社内データベースから入手したデータ、同社の業界専門家チームによるセカンダリーおよびプライマリー調査を用いて作成されています。

注)本レポートの一部のセクションは、該当疾患におけるデータの可用性や妥当性に基づいて、削除または変更される場合があります。

■調査範囲

  • 開発中の内臓機能アッセイを広範にカバーします。
  • 主要なパイプライン製品の詳細、ライセンスおよびコラボレーションの詳細、およびその他の開発活動を含みます。
  • 内臓機能アッセイの開発に関与した主要企業とパイプラインプロジェクトをレビューします。
  • 早期開発から承認/上市段階までの様々な開発段階に基づいてパイプライン製品をカバーします。
  • パイプライン製品に特有の進行中の臨床試験の重要な臨床試験データを提供します。
  • セグメント/産業における最近の動向を取り上げます。

レポート詳細

目次

1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Organ Function Assays Overview

3 Products under Development
3.1 Organ Function Assays - Pipeline Products by Stage of Development
3.2 Organ Function Assays - Pipeline Products by Territory
3.3 Organ Function Assays - Pipeline Products by Regulatory Path
3.4 Organ Function Assays - Pipeline Products by Estimated Approval Date
3.5 Organ Function Assays - Ongoing Clinical Trials

4 Organ Function Assays - Pipeline Products under Development by Companies
4.1 Organ Function Assays Companies - Pipeline Products by Stage of Development
4.2 Organ Function Assays - Pipeline Products by Stage of Development

5 Organ Function Assays Companies and Product Overview
5.1 Boditech Med Inc Company Overview
5.1.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 China Medical Technologies Inc (Inactive) Company Overview
5.2.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cornell University Company Overview
5.3.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview
5.4 Daxor Corp Company Overview
5.4.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 DSX Therapeutics LLC Company Overview
5.5.1 DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 French National Institute of Health and Medical Research Company Overview
5.6.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.7 HepQuant Llc Company Overview
5.7.1 HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Humedics GmbH Company Overview
5.8.1 Humedics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.9 Merck Millipore Corp Company Overview
5.9.1 Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Myriad Genetics Inc Company Overview
5.10.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Proteome Sciences Plc Company Overview
5.11.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Radboud University Medical Centre Company Overview
5.12.1 Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview
5.13 Schnellgen, Inc Company Overview
5.13.1 Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Organ Function Assays- Recent Developments
6.1 Oct 01, 2019: Fortress Diagnostics announces £8m investment in new headquarters
6.2 Sep 25, 2019: Myriad Genetics expands Board of Directors with two additional members
6.3 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
6.4 Aug 27, 2019: Chris Cournoyer joins CareDx Board of Directors
6.5 Aug 13, 2019: Myriad Genetics reports fiscal fourth-quarter and full-year 2019 financial results
6.6 Aug 01, 2019: CareDx reports second quarter 2019 results
6.7 Jul 29, 2019: Siemens Healthineers continues to drive growth forward
6.8 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers
6.9 Jul 02, 2019: Grace Colon succeeds Amy Abernethy on the CareDx Board
6.10 May 08, 2019: CareDx reports first quarter 2019 results
6.11 May 07, 2019: Myriad Genetics reports fiscal third-quarter 2019 financial results
6.12 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter
6.13 Apr 04, 2019: HepQuant’s Disease Severity Index (DSI) demonstrates hepatic functional improvement in high percentage of NASH patients treated with obeticholic acid: Results from INTERCEPT 747-117
6.14 Mar 06, 2019: CareDx reports fourth quarter and FY 2018 results
6.15 Mar 04, 2019: Daxor Announces Rise in Kit Sales and Files Form N-CSR For 2018
6.16 Feb 20, 2019: Keith Hoffman joins HepQuant as Clinical Lab Manager
6.17 Feb 14, 2019: First patient enrolled in a pivotal trial of the HepQuant SHUNT Liver Diagnostic Test
6.18 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim
6.19 Feb 05, 2019: Myriad Genetics reports fiscal second-quarter 2019 financial results
6.20 Jan 23, 2019: Proteome Sciences: Year-end trading update
6.21 Jan 07, 2019: CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results
6.22 Dec 31, 2018: Myriad Genetics announced its former CEO Peter Durkee Meldrum passed away
6.23 Dec 17, 2018: CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA
6.24 Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed
6.25 Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed
6.26 Nov 26, 2018: CareDx names Reginald Seeto, MB.BS, as president and chief business officer
6.27 Nov 26, 2018: CareDx strengthens executive leadership team with the appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer
6.28 Nov 09, 2018: HepQuant receives IDE approval from U.S. FDA to initiate clinical trial of the SHUNT Liver Diagnostic Kit
6.29 Nov 09, 2018: Mayo Clinic elects Kent Thielen, M.D., CEO of its Florida operations; Mayo's board of trustees also names two new members
6.30 Nov 08, 2018: CareDx reports third quarter results
6.31 Nov 06, 2018: Proteome Sciences: Trading update confirmation of preferred provider status
6.32 Nov 05, 2018: Siemens Healthineers with strong finish in fourth quarter, full year targets for fiscal 2018 achieved

7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Organ Function Assays - Pipeline Products by Stage of Development
Table 2: Organ Function Assays - Pipeline Products by Territory
Table 3: Organ Function Assays - Pipeline Products by Regulatory Path
Table 4: Organ Function Assays - Pipeline Products by Estimated Approval Date
Table 5: Organ Function Assays - Ongoing Clinical Trials
Table 6: Organ Function Assays Companies - Pipeline Products by Stage of Development
Table 7: Organ Function Assays - Pipeline Products by Stage of Development
Table 8: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Cornell University Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 24: DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 27: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Table 30: HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Humedics GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Glossary

List of Figures
Figure 1: Organ Function Assays - Pipeline Products by Stage of Development
Figure 2: Organ Function Assays - Pipeline Products by Territory
Figure 3: Organ Function Assays - Pipeline Products by Regulatory Path
Figure 4: Organ Function Assays - Pipeline Products by Estimated Approval Date
Figure 5: Organ Function Assays - Ongoing Clinical Trials

発刊日

2019/11/01

体裁

PDF / 68ページ

販売価格

2,500USD

発行

GlobalData

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医療器具・機器

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE